Tanvex BioPharma
6541.TW
1.03 USD
-0.02
-1.90%
t
Overview
Last close
1.03 usd
Market cap
271.97M usd
52 week high
2.12 usd
52 week low
0.93 usd
Target price
1.64 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
13.1376
Price/Book Value
1.6784
Enterprise Value
308.38M usd
EV/Revenue
14.9416
EV/EBITDA
-9.0582
Key financials
Revenue TTM
20.64M usd
Gross Profit TTM
-28.20M usd
EBITDA TTM
-40.75M usd
Earnings per Share
-0.19 usd
Dividend
N/A usd
Total assets
240.14M usd
Net debt
46.90M usd
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
- Symbol6541.TW
- ExchangeTW
- IsinKYG8676P1037
- CountryCayman Islands
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterGeorge Town
- Web sitehttps://www.tanvex.com
